Revvity launches single and dual-test blood screening kit for Hepatitis B, Hepatitis C, and HIV in China

prnasia.com (Chinese)

Revvity launched a new blood screening test kit for Hepatitis B, Hepatitis C, and HIV. The kit offers high sensitivity, efficiency, and low sample loss. The innovative kit features both single and dual-sample testing modes, balancing throughput and efficiency. It uses multiplex PCR technology to detect three pathogens in one tube and employs automated magnetic bead extraction. This new solution integrates with Revvity's automated platforms, providing a comprehensive blood safety screening system. Revvity has nearly 30 years of experience in nucleic acid blood screening in China.


With a significance score of 3.1, this news ranks in the top 11% of today's 33773 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Revvity launches single and dual-test blood screening kit for Hepatitis B, Hepatitis C, and HIV in China | News Minimalist